• 1
    Polednak AP, Flannery JT. Brain, other central nervous system, and eye cancer. Cancer. 1995; 75: 330337.
  • 2
    Laws ER, Parney IF, Huang W, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003; 99: 467473.
  • 3
    Simpson R, Horton MD, Scott C, et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys. 1993; 26: 239244.
  • 4
    Kelly PJ, Hunt C. The limited value of cytoreductive surgery in elderly patients with malignant gliomas. Neurosurgery. 1994; 34: 6267.
  • 5
    Kreth FW, Warnke PC, Scheremet R, Ostertag CB. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme. J Neurosurg. 1993; 78: 762766.
  • 6
    Jeremic B, Milicic B, Grujicic D, Dagovic A, Aleksandrovich J. Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach. J Cancer Res Clin Oncol. 2003; 129: 477484.
  • 7
    Mohan D, Suh JH, Phan JL, Kupelian PA, Cohen BH, Barnett GH. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Int J Radiat Oncol Biol Phys. 1998; 42: 981987.
  • 8
    Obwegeser A, Ortler M, Seiwald M, Ulmer H, Kostron H. Therapy of glioblastoma multiforme: a cumulative experience of 10 years. Acta Neurochir (Wien). 1995; 137: 29333.
  • 9
    Shrieve DC, Alexander E, Black P, et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg. 1999; 90: 7277.
  • 10
    Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histolgical type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973–1991. J Neurosurg. 1998; 88: 110.
  • 11
    Fleury A, Menegoz F, Grosclaude P, et al. Descriptive epidemiology of cerebral gliomas in France. Cancer. 1997; 79: 11951202.
  • 12
    Barnholtz-Sloan JS, Sloan A, Schwartz AG. Relative survival and patterns of diagnosis analyzed by time period for individuals with primary malignant brain tumor, 1973–1997. J Neurosurg. 2003; 99: 458466.
  • 13
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y. Influence of extent of surgery and tumor location on treatment outcome of patients with glioblastoma multiforme treated with combined modality approach. J Neuro-Oncol. 1994; 21: 177185.
  • 14
    Diete S, Treuheit T, Dietzman K, Schmidt U, Wallesch CW. Sex differences in length of survival with malignant astrocytoma, but not with glioblastoma. J Neuro-Oncol. 2001; 53: 4749.
  • 15
    Mack TM. Cancer surveillance program of Los Angeles County. Natl Cancer Inst Monogr. 1977; 47: 99101.
  • 16
    Liu L, Deapen D, Bernstein L. Socioeconomic status and cancers of the female breast and reproductive organs: a comparison across racial/ethnic populations in Los Angeles County, California (United States). Cancer Causes Control. 1998; 9: 369380.
  • 17
    Liu L, Cozen W, Bernstein L, Ross RK, Deapen D. Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst. 2001; 93: 705709.
  • 18
    State of California, Department of Finance. Race/ethnic population with age and sex detail, 1970–2004. Sacramento: State of California, Department of Finance, 1998.
  • 19
    Breslow NE, Day DE. Statistical methods in cancer research. Volume 1: the analysis of case-control studies. IARC Scientific Publication No. 32. Lyon: International Agency for Research on Cancer, 1980.
  • 20
    Surawicz TS, Davis F, Freels S, Laws E, Menck HR. Brain tumor survival: results from the National Cancer Data Base. J Neuro-Oncol. 1998; 40: 151160.
  • 21
    Velema JP, Percy CL. Age curves of central nervous system tumor incidence in adults: variation of shape by histologic type. J Natl Cancer Inst. 1987; 79: 623629.
  • 22
    Muir C, Mack T, Waterhouse J, Powell J, Whelan S. Cancer incidence in five continents. IARC Scientific Publication No. 88. Lyon: International Agency for Research on Cancer, 1987.
  • 23
    Desmueles M, Mikkelsen T, Mao Y. Increasing incidence of primary malignant brain tumors: influence of diagnostic methods. J Natl Cancer Inst. 1992; 84: 442445.
  • 24
    Greig NH, Ries LG, Yancik R, Rapaport SI. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst. 1990; 82: 16211624.
  • 25
    Legler JM, Gloeckler-Ries LA, Smith MA, et al. Brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst. 1999; 91: 13821390.
  • 26
    Preston-Martin S. Descriptive epidemiology of primary tumors of the brain, cranial nerves and cranial meninges in Los Angeles County. Neuroepidemiology. 1989; 8: 283295.
  • 27
    Buell P, Dunn JE, Breslow L. The occupational-social class risks of cancer mortality in men. Cancer. 1960; 12: 600621.
  • 28
    Kallio M, Sankila R, Jaaskelainen J, Karjalainen S, Hakulinen T. A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984. Cancer. 1991; 68: 13941400.
  • 29
    Lacroiz M, Abi-Said D. Fourney DR, et al. Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma. J Neurosurg. 1993; 78: 762766.
  • 30
    Sawaya R. Extent of resection in malignant gliomas: a critical summary. J Neuro-Oncol. 1999; 42: 303305.
  • 31
    Wood JR, Green SB, Shapiro WR. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the brain tumor cooperative group. J Clin Oncol. 1988; 6: 338343.